GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Allergan, Inc. (AGN) [hlAlert]

Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. The Company is engaged in discovering, developing and commercializing specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics,
medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries globally. In January 2007, the Company completed the acquisition of Groupe Corneal Laboratoires (Corneal). In October 2007, the Company completed the acquisition of Esprit Pharma Holding Company, Inc. (Esprit). In July 2008, the Company acquired the Aczone (dapsone) gel 5% from QLT USA, Inc. (QLT), a wholly owned subsidiary of QLT Inc. The Company operates in two business segments: specialty pharmaceuticals and medical devices.
.
( Total: 30 Current Stock Recommendations )
Allergan, Inc.   (30)
Hold 40% Buy 60%
Related companies
Sanofi-aventis Sa   (17)
Hold 47% Buy 53%
Novo Nordisk A/s   (18)
Sell 17% Hold 44% Buy 39%
Amgen Inc.   (30)
Hold 47% Buy 53%
Gilead Sciences, ...   (48)
Sell Hold 15% Buy 81%
Teva Pharmaceutical ...   (41)
Hold 27% Buy 73%
Celgene Corporation   (44)
Sell Hold Buy 84%
Allergan Plc   (28)
Hold 29% Buy 71%
Biogen Idec Inc   (41)
Sell Hold 27% Buy 68%
Filter by Gains:   
  
Rating:
Hold AGN
up 21.85 %

Rating:
Hold AGN
up 17.88 %
Allergan, Inc. (AGN) downgraded to Hold by Stifel
Monday,  Dec 15, 2014  8:25 AM ET

Rating:
Buy AGN
up 62.20 %

Rating:
Buy AGN
up 17.88 %

Rating:
Buy AGN
up 21.85 %
Allergan, Inc. (AGN) rated Buy with price target $200 by UBS
Tuesday,  Jul 22, 2014  12:00 AM ET

Rating:
Hold AGN
Allergan, Inc. (AGN) rated Hold by Stifel
Monday,  Apr 28, 2014  12:00 AM ET

Rating:
Hold AGN
up 37.70 %
Allergan, Inc. (AGN) downgraded to Hold by Argus
Tuesday,  Apr 22, 2014  12:00 AM ET

Rating:
Buy AGN
up 37.70 %

Rating:
Buy AGN
up 166.78 %

Rating:
Buy AGN
up 584.67 %

Rating:
Buy AGN
up 180.87 %
Allergan, Inc. (AGN) upgraded to Outperform by Wells Fargo
Tuesday,  Dec 24, 2013  8:25 AM ET

Rating:
Buy AGN
up 181.54 %

Rating:
Buy AGN
up 309.77 %
Allergan, Inc. (AGN) rated Buy with price target $116 by UBS
Friday,  Dec 20, 2013  12:25 PM ET

Rating:
Buy AGN
up 264.34 %
Allergan, Inc. (AGN) rated Buy with price target $110 by Argus
Thursday,  Oct 31, 2013  9:25 AM ET

Rating:
Buy AGN
up 663.04 %
Allergan, Inc. (AGN) rated Outperform by Credit Suisse
Wednesday,  Oct 9, 2013  8:25 AM ET

Your Recent Stocks
SymbolLastChange
AGN 227.17 down  -25.75 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy